PANIC-ATTAC: A mouse model for inducible and reversible β-cell ablation

Diabetes

Volumn 57, Issue 8, 2008, Pages 2137-2148

  Wang, Zhao V ^a,b   Mu, James ^c   Schraw, Todd D ^b   Gautron, Laurent ^b   Elmquist, Joel K ^b   Zhang, Bei B ^c   Brownlee, Michael ^a   Scherer, Philipp E ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [2 (4 PHENOXY 2 PROPYLPHENOXY)ETHYL]INDOLE 5 ACETIC ACID; CASPASE 8; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TRANSPORTER 2; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; SITAGLIPTIN; STREPTOZOCIN; UNCLASSIFIED DRUG; AP20187; CASP8 PROTEIN, MOUSE; CASPASE; DRUG DERIVATIVE; FK 506 BINDING PROTEIN; PEPTIDE; TACROLIMUS; VENOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL DEATH; CELL LOSS; CELL PROTECTION; CELL REGENERATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MODEL; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; MOUSE; NONHUMAN; PANCREAS INJURY; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; STEM CELL; STREPTOZOCIN DIABETES; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; TREATMENT RESPONSE; ANIMAL; CYTOLOGY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; GLUCOSE TOLERANCE TEST; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENE;

ANIMALS; APOPTOSIS; CASPASE 8; CASPASES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE TOLERANCE TEST; INSULIN-SECRETING CELLS; MALE; MICE; MICE, TRANSGENIC; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TACROLIMUS; TACROLIMUS BINDING PROTEINS; TRANSGENES; VENOMS;

EID: 50949114536     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-1631     Document Type: Article

References (36)

1. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053, 2004
2. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238, 2000
3. Lardon J, Huyens N, Rooman I, Bouwens L: Exocrine cell transdifferen- tiation in dexamethasone-treated rat pancreas. Virchows Arch 444:61-65, 2004
4. Bonner-Weir S, Toschi E, Inada A, Reitz P, Fonseca SY, Aye T, Sharma A: The pancreatic ductal epithelium serves as a potential pool of progenitor cells. Pediatr Diabetes 5 (Suppl. 2):16-22, 2004
5. Rajagopal J, Anderson WJ, Kume S, Martinez OI, Melton DA: Insulin staining of ES cell progeny from insulin uptake. Science 299: 363, 2003
6. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R: Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292:1389-1394, 2001
7. Hao E, Tyrberg B, Itkin-Ansari P, Lakey JR, Geron I, Monosov EZ, Barcova M, Mercola M, Levine F: Beta-cell differentiation from nonendocrine epithelial cells of the adult human pancreas. Nat Med 12:310-316, 2006
8. Dor Y, Brown J, Martinez OI, Melton DA: Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41-46, 2004
9. Pajvani UB, Trujillo ME, Combs TP, Iyengar P, Jelicks L, Roth KA, Kitsis RN, Scherer PE: Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nat Med 11:797-803, 2005
10. Mu J, Woods J, Zhou YP, Roy RS, Li Z, Zycband E, Feng Y, Zhu L, Li C, Howard AD, Moller DE, Thornberry NA, Zhang BB: Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic β-cell mass and function in a rodent model of type 2 diabetes. Diabetes 55:1695-1704, 2006
11. Meier JJ, Lin JC, Butler AE, Galasso R, Martinez DS, Butler PC: Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia 49:1838-1844, 2006
12. Carley AN, Semeniuk LM, Shimoni Y, Aasum E, Larsen TS, Berger JP, Severson DL: Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function. Am J Physiol Endocrinol Metab 286:E449-E455, 2004
13. Kim D, Wang L, Beconi M, Eiermann GJ, Fisher MH, He H, Hickey GJ, Kowalchick JE, Leiting B, Lyons K, Marsilio F, McCann ME, Patel RA, Petrov A, Scapin G, Patel SB, Roy RS, Wu JK, Wyvratt MJ, Zhang BB, Zhu L, Thornberry NA, Weber AE: (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6- dihydro[1,2,4]triazolo[4,3-a] pyrazin-7(8H)- yl]-1-(2,4,5-trifluorophenyl)bu- tan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. J Med Chem 48:141-151, 2005
14. Clackson T, Yang W, Rozamus LW, Hatada M, Amara JF, Rollins CT, Stevenson LF, Magari SR, Wood SA, Courage NL, Lu X, Cerasoli F Jr, Gilman M, Holt DA: Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity. Proc Natl Acad SciUSA 95:10437-10442, 1998
15. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM: An induced proximity model for caspase-8 activation. J Biol Chem 273:2926-2930, 1998
16. Wencker D, Chandra M, Nguyen K, Miao W, Garantziotis S, Factor SM, Shirani J, Armstrong RC, Kitsis RN: A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 111:1497-1504, 2003
17. Gannon M, Shiota C, Postic C, Wright CV, Magnuson M: Analysis of the Cre-mediated recombination driven by rat insulin promoter in embryonic and adult mouse pancreas. Genesis 26:139-142, 2000
18. Laybutt DR, Glandt M, Xu G, Ahn YB, Trivedi N, Bonner-Weir S, Weir GC: Critical reduction in beta-cell mass results in two distinct outcomes over time: adaptation with impaired glucose tolerance or decompensated diabetes. J Biol Chem 278:2997-3005, 2003
19. Bonner-Weir S, Trent DF, Weir GC: Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. J Clin Invest 71: 1544-1553, 1983
20. Shimabukuro M, Zhou YT, Levi M, Unger RH: Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad SciUSA 95:2498-2502, 1998
21. Goke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, Goke B: Exendin-4 is a high potency agonist and truncated exendin-(9 -39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. J Biol Chem 268:19650-19655, 1993
22. Xu G, Stoffers DA, Habener JF, Bonner-Weir S: Exendin-4 stimulates both β-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48:2270-2276, 1999
23. Rosen ED, Kulkarni RN, Sarraf P, Ozcan U, Okada T, Hsu CH, Eisenman D, Magnuson MA, Gonzalez FJ, Kahn CR, Spiegelman BM: Targeted elimina- tion of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose ho- meostasis. Mol Cell Biol 23:7222-7229, 2003
24. Brunham LR, Kruit JK, Pape TD, Timmins JM, Reuwer AQ, Vasanji Z, Marsh BJ, Rodrigues B, Johnson JD, Parks JS, Verchere CB, Hayden MR: Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med 13:340-347, 2007
25. Wang RN, Kloppel G, Bouwens L: Duct- to islet-cell differentiation and islet growth in the pancreas of duct-ligated adult rats. Diabetologia 38:1405-1411, 1995
26. Schnedl WJ, Ferber S, Johnson JH, Newgard CB: STZ transport and cytotoxicity: specific enhancement in GLUT2-expressing cells. Diabetes 43:1326-1333, 1994
27. Orci L, Ravazzola M, Baetens D, Inman L, Amherdt M, Peterson RG, Newgard CB, Johnson JH, Unger RH: Evidence that down-regulation of beta-cell glucose transporters in non-insulin-dependent diabetes may be the cause of diabetic hyperglycemia. Proc Natl Acad SciUSA87:9953- 9957, 1990
28. Herrera PL, Huarte J, Zufferey R, Nichols A, Mermillod B, Philippe J, Muniesa P, Sanvito F, Orci L, Vassalli JD: Ablation of islet endocrine cells by targeted expression of hormone-promoter-driven toxigenes. Proc Natl Acad SciUSA 91:12999 -13003, 1994
29. Nir T, Melton DA, Dor Y: Recovery from diabetes in mice by beta cell regeneration. J Clin Invest 117:2553-2561, 2007
30. Cano DA, Rulifson IC, Heiser PW, Swigart LB, Pelengaris S, German M, Evan GI, Bluestone JA, Hebrok M: Regulated β-cell regeneration in the adult mouse pancreas. Diabetes 57:958-966, 2008
31. Schisler JC, Jensen PB, Taylor DG, Becker TC, Knop FK, Takekawa S, German M, Weir GC, Lu D, Mirmira RG, Newgard CB: The Nkx6.1 homeodomain transcription factor suppresses glucagon expression and regulates glucose-stimulated insulin secretion in islet beta cells. Proc Natl Acad SciUSA102:7297-7302, 2005
32. Dabelea D, Pettitt DJ: Intrauterine diabetic environment confers risks for type 2 diabetes mellitus and obesity in the offspring, in addition to genetic susceptibility. J Pediatr Endocrinol Metab 14:1085-1091, 2001
33. Aerts L, Van Assche FA: Animal evidence for the transgenerational development of diabetes mellitus. Int J Biochem Cell Biol 38:894-903, 2006
34. Hay WW Jr: Recent observations on the regulation of fetal metabolism by glucose. J Physiol 572:17-24, 2006
35. Teta M, Rankin MM, Long SY, Stein GM, Kushner JA: Growth and regeneration of adult beta cells does not involve specialized progenitors. Dev Cell 12:817-826, 2007
36. Pang K, Mukonoweshuro C, Wong GG: Beta cells arise from glucose transporter type 2 (Glut2)-expressing epithelial cells of the developing rat pancreas. Proc Natl Acad Sc iUSA91:9559-9563, 1994